Research Chemical Designation & Liability

Compounds indexed in the MinMaxMuscle archive are strictly for laboratory research and development. They are NOT approved for human consumption. Theoretical dosing data is aggregated from clinical literature and must not be construed as medical instruction. Professional medical consultation is mandatory prior to any research application.

Full Disclaimer
Archive Identifier

Carnosine

Anti-Aging

Molecular Dossier

  • Rank Index: 59
  • Status: Research Only
  • What does this mean?
  • Molecular Structure: MW: 226.23 g/mol | Formula: C9H14N4O3 | CAS: 305-84-0 | Dipeptide

About Carnosine

Naturally occurring dipeptide (beta-alanyl-L-histidine) found at high concentrations in muscle and brain tissue. Acts as a broad-spectrum antioxidant, pH buffer, and potent anti-glycation agent. Research shows it inhibits formation of advanced glycation end-products (AGEs), protects neurons, and may slow cellular senescence markers.

Clinical Focus

Antioxidant, Advanced Glycation Endproduct Inhibition, Cellular Longevity

Archival Aliases

L-Carnosine, Beta-Ala-His, Ignotine

Frequently Asked Questions

Clinical Data Matrix

Parameter Clinical Value
Molecular Weight MW: 226.23 g/mol | Formula: C9H14N4O3 | CAS: 305-84-0 | Dipeptide
Primary Pathway Anti-Aging
Research Phase Research Only

Clinical Pros

  • Highly selective receptor modulation
  • Documented efficacy in Phase II trials
  • Minimal systemic cross-reactivity

Research Limitations

  • Limited long-term human data
  • Strict storage and reconstitution requirements
  • Potential for acute homeostatic feedback loops

Community Discussion

Share your questions and experiences with other researchers in the forum.

Discuss in Forum

Clinical Reference Nodes

[REF 1] pubmed.ncbi.nlm.nih.gov
[REF 2] pubmed.ncbi.nlm.nih.gov
[REF 3] pubmed.ncbi.nlm.nih.gov

Data Verified: 2026-04-14

Synergistic Matrix